Please assess the completion status of the following clinical trial:

Trial Title: Efficacy of Hematoma Block on Postoperative Pain After Femoral Intramedullary Rodding: A Randomized Trial

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Trauma patient at the University of Cincinnati Medical Center~* Skeletally mature patients~* Have an isolated, closed, acute traumatic femoral shaft fracture to be treated with a closed reduction and reamed intramedullary rod fixation~Exclusion Criteria:~* Unable to provide informed consent~* Member of a vulnerable patient population~* Have additional injuries~* Have a history of prior existing narcotic use or chronic pain management issues on presentation

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Hematoma block (Type: EXPERIMENTAL): Fracture site injection of 20 mL of 0.5% ropivacaine with an 18-gauge needle (150 mm length).
- Normal saline injection (Type: PLACEBO_COMPARATOR): Fracture site injection of 20ml of normal saline.

Based on this trial design, predict the completion outcome and termination type (if applicable).